Using Twitter for the identification of COVID-19 vaccine-associated haematological adverse events

Charles L. Bennett; Krishna Gundabolu; Larry W. Kwak; Benjamin Djulbegovic; Oscar Champigneulle; Brian Josephson; Linda Martin; Steven T. Rosen

doi:10.1016/S2352-3026(21)00378-1

Using Twitter for the identification of COVID-19 vaccine-associated haematological adverse events

Charles L. Bennett, Krishna Gundabolu, Larry W. Kwak, Benjamin Djulbegovic, Oscar Champigneulle, Brian Josephson, Linda Martin, Steven T. Rosen

Research output: Contribution to journal › Article › peer-review

4 Scopus citations

Original language	English (US)
Pages (from-to)	e12-e13
Journal	The Lancet Haematology
Volume	9
Issue number	1
DOIs	https://doi.org/10.1016/S2352-3026(21)00378-1
State	Published - Jan 2022

ASJC Scopus subject areas

Hematology

Access to Document

10.1016/S2352-3026(21)00378-1

Cite this

@article{f17fcb608df347699c2774f7879eaaef,

title = "Using Twitter for the identification of COVID-19 vaccine-associated haematological adverse events",

author = "Bennett, {Charles L.} and Krishna Gundabolu and Kwak, {Larry W.} and Benjamin Djulbegovic and Oscar Champigneulle and Brian Josephson and Linda Martin and Rosen, {Steven T.}",

note = "Funding Information: STR, LWK, BD, and CLB declare research funding from the National Institutes of Health. KG is the institutional primary investigator for clinical trials that received grants from Incyte, Samus, Pfizer, and Autolus. The other authors declare no competing interests. This work received support from the National Cancer Institute (1R01CA102713-01 [CLB]) and unrestricted funding from the Rick Martin Initiative on Pharmaceutical Drug Safety at the Beckman Institute and the City of Hope Comprehensive Center (CLB). ",

year = "2022",

month = jan,

doi = "10.1016/S2352-3026(21)00378-1",

language = "English (US)",

volume = "9",

pages = "e12--e13",

journal = "The Lancet Haematology",

issn = "2352-3026",

publisher = "Lancet Publishing Group",

number = "1",

}

TY - JOUR

T1 - Using Twitter for the identification of COVID-19 vaccine-associated haematological adverse events

AU - Bennett, Charles L.

AU - Gundabolu, Krishna

AU - Kwak, Larry W.

AU - Djulbegovic, Benjamin

AU - Champigneulle, Oscar

AU - Josephson, Brian

AU - Martin, Linda

AU - Rosen, Steven T.

N1 - Funding Information: STR, LWK, BD, and CLB declare research funding from the National Institutes of Health. KG is the institutional primary investigator for clinical trials that received grants from Incyte, Samus, Pfizer, and Autolus. The other authors declare no competing interests. This work received support from the National Cancer Institute (1R01CA102713-01 [CLB]) and unrestricted funding from the Rick Martin Initiative on Pharmaceutical Drug Safety at the Beckman Institute and the City of Hope Comprehensive Center (CLB).

PY - 2022/1

Y1 - 2022/1

UR - http://www.scopus.com/inward/record.url?scp=85121594448&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85121594448&partnerID=8YFLogxK

U2 - 10.1016/S2352-3026(21)00378-1

DO - 10.1016/S2352-3026(21)00378-1

M3 - Article

C2 - 34971576

AN - SCOPUS:85121594448

SN - 2352-3026

VL - 9

SP - e12-e13

JO - The Lancet Haematology

JF - The Lancet Haematology

IS - 1

ER -

Using Twitter for the identification of COVID-19 vaccine-associated haematological adverse events

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this